Fortress Biotech (FBIO) Preferred Dividend Payments (2011 - 2026)
Fortress Biotech (FBIO) posted quarterly Preferred Dividend Payments of $2.3 million for Q4 2025, down 21.68% year-over-year from $2.9 million in Q4 2024, and up 4.0% quarter-over-quarter from $2.2 million in Q3 2025.
Analysis
Fortress Biotech (FBIO) Preferred Dividend Payments (2011 - 2026) Analysis & Trends
Fortress Biotech's Preferred Dividend Payments history runs 5 years deep, the most recent figure standing at $2.3 million for Q4 2025.
- In Q4 2025, Preferred Dividend Payments fell 21.68% year-over-year to $2.3 million; the TTM figure through Dec 2025 stood at $9.5 million (down 0.6% YoY), while the FY2025 annual figure was $8.7 million, down 12.09% from the prior year.
- Preferred Dividend Payments for Q4 2025 stood at $2.3 million, up from $2.2 million in the prior quarter.
- The five-year high for Preferred Dividend Payments was $2.9 million in Q4 2024, with the low at $2.0 million in Q2 2023.
- The 4-year median for Preferred Dividend Payments is $2.1 million (2022), against an average of $2.2 million.
- The sharpest annual moves came in 2024 and 2025: Preferred Dividend Payments soared 43.77% in 2024, then retreated 21.68% in 2025.
- Fortress Biotech's Preferred Dividend Payments stood at $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then jumped by 43.77% to $2.9 million in 2024, then declined by 21.68% to $2.3 million in 2025.
- Business Quant data shows FBIO's Preferred Dividend Payments at $2.3 million in Q4 2025, $2.2 million in Q3 2025, and $2.1 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | - |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 2.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.01 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 2.13 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 2.89 Mn |
| Sep 30, 2024 | 2.17 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 2.01 Mn |
| Sep 30, 2023 | 2.01 Mn |
| Jun 30, 2023 | 2.01 Mn |
| Dec 31, 2022 | 2.01 Mn |
| Sep 30, 2022 | 2.01 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Jun 30, 2011 | -5.86 Mn |